Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Biogen Inc. announced that the FDA has granted Breakthrough Therapy Designation to its investigational antisense oligonucleotide, salanersen, for treating spinal muscular atrophy (SMA). Supported by positive Phase 1b data showing motor function improvements and slowing neurodegeneration in children with SMA, salanersen offers potential high efficac…
Rezolute, Inc., a late-stage biotech company focused on treatments for refractory hypoglycemia due to hyperinsulinism, announced four presentations at the 2026 Endocrine Society Annual Meeting. These include data from the Phase 3 sunRIZE study of their drug ersodetug, which previously failed to meet primary endpoints but showed consistent glycemic …
Plus Therapeutics announced that CNSide Diagnostics, its wholly owned subsidiary, has achieved College of American Pathologists (CAP) accreditation for its Houston-based clinical laboratory. This accreditation validates the laboratory's high standards and quality controls, strengthening its position to expand the commercial use of the CNSide® CSF A…
Jade Biosciences shares plunged in pre-market trading after the company priced a sizeable secondary offering well below the prior session close. The planned sale of 10 million shares at $15.00, with a 30-day option for underwriters to buy an additional 1.5 million shares, created dilution concerns and anchored near-term price expectations, while a …
At least seven students from a polytechnic in Zamfara State were seized by gunmen in the early hours of June 3, police said, after attackers stormed rented student housing on the outskirts of Kaura Namoda town. Security forces were dispatched but the assailants had fled before arrival. Authorities say search-and-rescue efforts have been intensified…
Goldman Sachs upgraded Wartsila from Sell to Neutral and raised its 12-month price target to €34 from €26.30 after boosting adjusted EBIT estimates for 2026-2029 by 12-18%. The change follows the company’s announcements of substantial capacity investments that together increase technical production capacity by 65% above 2025 levels and a management…
ITV's chief executive, Carolyn McCall, said the broadcaster remains in active discussions with Comcast's Sky about a potential sale of its media and entertainment arm. McCall declined to provide further specifics at the Enders TMT Leaders Live conference, citing ITV's obligations as a publicly traded company. The proposed transaction, first announc…
Grifols is trading cheaply (market cap $6.42B, P/E ~10.6, P/B ~0.81) while the underlying plasma-derived therapies market is growing strongly. Near-term headline risk out of Canada has hit the stock, but resolution or containment of that regulatory episode, combined with improved plasma self-sufficiency trends and continued demand for immunoglobuli…
Microchip Technology's Armenian office has received a U.S. Department of Commerce export license authorizing them to develop advanced FPGA technologies within Armenia. This approval strengthens Armenia's role in the global semiconductor supply chain and supports Microchip’s commitment to innovation through expanded global engineering collaboration.
NBT Bancorp (NBTB) trades at a modest P/E of ~12.7 and a P/B near 1.22, pays a 3.2% yield, and has scale ($16.11B assets) following the Evans Bancorp merger. This trade targets $52 with a $40 stop, keyed to stable fundamentals, improving footprint in Upstate New York, and attractive cash flow metrics.
Less than two weeks before the 2026 World Cup begins in North America, public excitement in Argentina is noticeably restrained compared with the frenetic atmosphere that followed the team's 2022 triumph in Qatar. While promotional campaigns featuring Lionel Messi and the national squad are widespread, many fans describe a quieter optimism and lower…
SAP stock jumped in pre-market trading after the vendor used its Sapphire 2026 conference to outline a sweeping AI strategy called the "Autonomous Enterprise," backed by an immediate rollout of assistant and agent capabilities, a €100 million partner AI fund, an intended acquisition of Dremio, and a substantial commitment to Prior Labs. The moves, …
Solidion Technology Inc. (NASDAQ:STI) saw its shares climb 200% on Thursday after revealing a patented Generation Extreme-Climate Battery (Gen-ECB) platform designed to function across a wide temperature range for space applications. The company highlighted graphene-based thermal and radiation protections, demonstrated cycle life at cold temperatur…
Bank of America upgraded UnitedHealth Group to Buy from Neutral and lifted its price target to $450 from $420, citing improving medical-cost trends and near-term utilization data that set up a favorable second-quarter earnings backdrop. Analyst Kevin Fischbeck says BofA's revised estimates place the new target at 21.4x 2027 figures and that the fir…
Microchip Technology is showing early signs of margin stabilization while its data center business is scaling quickly. With the Data Center Solutions unit posting $302.7M in 2025 and management projecting roughly $500M in 2026 (a 65% increase), the stock can re-rate if margins and free cash flow continue improving. This is a tactical swing trade: e…
BofA Securities upgraded Epiroc AB to Buy from Underperform and FLSmidth to Buy from Neutral, citing a wave of copper project final investment decisions (FIDs) over the next four years. The bank sees material upside to upstream original equipment orders in 2026-2027 and raised price targets for both Epiroc and FLSmidth, while reiterating its Buy on…
Global-e Online Ltd., a leading global direct-to-consumer e-commerce platform, announced that its Board of Directors has authorized a new share repurchase program of up to $500 million. This follows completion of about 80% of their previous $200 million repurchase plan. The program aims to return capital to shareholders while supporting strategic i…
Click Holdings Limited (NASDAQ: CLIK), a leader in AI-powered human resources and senior care solutions in Hong Kong, announced a strong Q3 financial performance with a 73% year-over-year increase in revenue to HK$38 million. Growth was driven by higher demand for premium nursing and elderly care services, alongside expanded logistics capacity. The…
GH Research PLC reported successful Phase 2a trial results for inhaled mebufotenin (GH001) in treating postpartum depression, with 100% remission within two hours sustained through 8 days. The treatment was well-tolerated with minimal side effects and only brief breastfeeding interruption. The company also announced upcoming presentations on Phase …
REalloys Inc., a U.S.-based mine-to-magnet rare earth company, signed a non-binding Letter of Intent with Patriot Exploration & Mining, a U.S. rare earth exploration firm with access to 2 billion metric tons of rare earth material across the Appalachian Basin. The agreement establishes a framework for REalloys to obtain priority access to up to 30%…
LeonaBio, a clinical-stage biopharmaceutical company, presented its ALS drug candidate brelgometon (ATH-1105) at the 5th Annual ALS Drug Development Summit. The presentation highlighted the oral, brain-penetrant drug's mechanism and supporting Phase 1 and preclinical data. LeonaBio plans to initiate a randomized, placebo-controlled Phase 2 proof-of…
Regeneron Pharmaceuticals announced upcoming presentations at the 2026 ADA and ENDO meetings highlighting new clinical and preclinical data from their metabolic disease, ophthalmology, and rare disease drug pipelines. Key focus includes the Phase 2 COURAGE trial on muscle and metabolic health, early data on Graves' and thyroid eye disease, and pivo…
Tilray Brands' subsidiary, Breckenridge Distillery, has introduced Breckenridge Rye Whiskey, a bold and richly flavored 100 proof rye whiskey crafted at 9,600 feet in Colorado. This new product builds on the distillery's reputation for quality and innovation and will be available in Colorado now and nationally in summer 2026.
Ocular Therapeutix, a biopharmaceutical company specializing in retinal diseases, announced its scheduled presentations at Clinical Trials at the Summit 2026. The company will share updates on its Phase 3 clinical trials of AXPAXLI (OTX-TKI), an investigational treatment targeting wet age-related macular degeneration and diabetic retinal diseases. …
Gogo Inc. announced that its SD Government division secured a multi-year $7.5 million contract with NOAA to provide L-Band satellite communications, ground infrastructure, cybersecurity solutions, and advanced cockpit software for NOAA's Hurricane Hunter aircraft, supporting vital storm research and real-time data transmission ahead of hurricane se…
